Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02923245 · ClinicalTrials.gov registry record · NA

POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound

A NA study of Pelvic Pain and Abdominal Pain, sponsored by Lifespan.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT02923245 is a NA study of Pelvic Pain and Abdominal Pain that has completed, run by Lifespan. The registered enrollment target is 120 participants, below the 366-participant average among 23 other Pelvic Pain trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02923245, a NA study of Pelvic Pain and Abdominal Pain, has completed, sponsored by Lifespan.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the accuracy and utility of point-of-care ultrasound (POCUS) of the bladder compared to patient's sensation of bladder fullness in predicting the ability to successfully perform a comprehensive transabdominal pelvic ultrasound in the pediatric Emergency Department (ED). We hypothesize that POCUS can more accurately and more quickly determine adequate bladder fullness to successfully perform transabdominal pelvic ultrasound than patient's perception of bladder fullness.

Interventions

  • OTHER point-of-care ultrasound

Study Locations (1)

Rhode Island

  • Hasbro Children's Hospital Emergency Department - Providence

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2015-09
Est. Completion 2016-11-05
Phase NA

Sponsor

Lifespan

18 total trials

What the Registry Record Tells You About NCT02923245

The ClinicalTrials.gov registry entry for NCT02923245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 366-participant average among 23 other Pelvic Pain trials with a reported enrollment target (67% lower). The listed sponsor is Lifespan, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pelvic Pain appearing as the primary indexed condition, and to 1 intervention - of which point-of-care ultrasound is the first listed.

NCT02923245 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02923245 about?

NCT02923245 is a clinical study titled "POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound". The purpose of this study is to assess the accuracy and utility of point-of-care ultrasound (POCUS) of the bladder compared to patient's sensation of bladder fullness in predicting the ability to successfully perform a comprehensive transabdominal pelvic ultrasound in the pediatric Emergency Departm...

What is the current status of trial NCT02923245?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2015-09. Estimated completion is 2016-11-05.

What conditions does trial NCT02923245 study?

This clinical trial studies the following conditions: Pelvic Pain, Abdominal Pain.

What interventions are being tested in trial NCT02923245?

The interventions under investigation include: point-of-care ultrasound (OTHER).

Who is sponsoring clinical trial NCT02923245?

This trial is sponsored by Lifespan, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02923245 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.